These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 23558784)

  • 1. A preclinical xenograft model of prostate cancer using human tumors.
    Lawrence MG; Taylor RA; Toivanen R; Pedersen J; Norden S; Pook DW; Frydenberg M; ; Papargiris MM; Niranjan B; Richards MG; Wang H; Collins AT; Maitland NJ; Risbridger GP
    Nat Protoc; 2013 May; 8(5):836-48. PubMed ID: 23558784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and characterization of efficient xenograft models for benign and malignant human prostate tissue.
    Wang Y; Revelo MP; Sudilovsky D; Cao M; Chen WG; Goetz L; Xue H; Sadar M; Shappell SB; Cunha GR; Hayward SW
    Prostate; 2005 Jul; 64(2):149-59. PubMed ID: 15678503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.
    Nemeth JA; Harb JF; Barroso U; He Z; Grignon DJ; Cher ML
    Cancer Res; 1999 Apr; 59(8):1987-93. PubMed ID: 10213511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brief report: a bioassay to identify primary human prostate cancer repopulating cells.
    Toivanen R; Berman DM; Wang H; Pedersen J; Frydenberg M; Meeker AK; Ellem SJ; Risbridger GP; Taylor RA
    Stem Cells; 2011 Aug; 29(8):1310-4. PubMed ID: 21674698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imatinib Spares cKit-Expressing Prostate Neuroendocrine Tumors, whereas Kills Seminal Vesicle Epithelial-Stromal Tumors by Targeting PDGFR-β.
    Jachetti E; Rigoni A; Bongiovanni L; Arioli I; Botti L; Parenza M; Cancila V; Chiodoni C; Festinese F; Bellone M; Tardanico R; Tripodo C; Colombo MP
    Mol Cancer Ther; 2017 Feb; 16(2):365-375. PubMed ID: 27980106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Change in morphological and functional cytodifferentiation induced by seminal vesicle mesenchyme in cell suspensions of rat Dunning prostatic adenocarcinoma cells.
    Hayashi N; Tsuji M; Sugimura Y; Kawamura J; Cunha GR
    Int J Cancer; 1996 Dec; 68(6):788-94. PubMed ID: 8980185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal capsule xenografting and subcutaneous pellet implantation for the evaluation of prostate carcinogenesis and benign prostatic hyperplasia.
    Nicholson TM; Uchtmann KS; Valdez CD; Theberge AB; Miralem T; Ricke WA
    J Vis Exp; 2013 Aug; (78):. PubMed ID: 24022657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishing prostate cancer patient derived xenografts: lessons learned from older studies.
    Russell PJ; Russell P; Rudduck C; Tse BW; Williams ED; Raghavan D
    Prostate; 2015 May; 75(6):628-36. PubMed ID: 25560784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel in vitro assay of tumor-initiating cells in xenograft prostate tumors.
    Silvers CR; Williams K; Salamone L; Huang J; Jordan CT; Zhou H; Palapattu GS
    Prostate; 2010 Sep; 70(13):1379-87. PubMed ID: 20687210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seminal Vesicle Tumor Microenvironment.
    Cimadamore A; Montironi R; Serni S; Campi R
    Adv Exp Med Biol; 2020; 1296():309-318. PubMed ID: 34185301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice.
    Klein KA; Reiter RE; Redula J; Moradi H; Zhu XL; Brothman AR; Lamb DJ; Marcelli M; Belldegrun A; Witte ON; Sawyers CL
    Nat Med; 1997 Apr; 3(4):402-8. PubMed ID: 9095173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignancy arising in seminal vesicles in the transgenic adenocarcinoma of mouse prostate (TRAMP) model.
    Yeh IT; Reddick RL; Kumar AP
    Prostate; 2009 May; 69(7):755-60. PubMed ID: 19170049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissociated primary human prostate cancer cells coinjected with the immortalized Hs5 bone marrow stromal cells generate undifferentiated tumors in NOD/SCID-γ mice.
    Chen X; Liu B; Li Q; Honorio S; Liu X; Liu C; Multani AS; Calhoun-Davis T; Tang DG
    PLoS One; 2013; 8(2):e56903. PubMed ID: 23451107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mixed epithelial-stromal tumor (MEST) of seminal vesicle: a proposal for unified nomenclature.
    Reikie BA; Yilmaz A; Medlicott S; Trpkov K
    Adv Anat Pathol; 2015 Mar; 22(2):113-20. PubMed ID: 25664946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel patient-derived intra-femoral xenograft model of bone metastatic prostate cancer that recapitulates mixed osteolytic and osteoblastic lesions.
    Raheem O; Kulidjian AA; Wu C; Jeong YB; Yamaguchi T; Smith KM; Goff D; Leu H; Morris SR; Cacalano NA; Masuda K; Jamieson CH; Kane CJ; Jamieson CA
    J Transl Med; 2011 Oct; 9():185. PubMed ID: 22035283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of primary patient-derived xenografts of palliative TURP specimens to study castrate-resistant prostate cancer.
    Lawrence MG; Pook DW; Wang H; Porter LH; Frydenberg M; Kourambas J; Appu S; Poole C; Beardsley EK; Ryan A; Norden S; Papargiris MM; Risbridger GP; Taylor RA
    Prostate; 2015 Sep; 75(13):1475-83. PubMed ID: 26177841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steroid hormones stimulate human prostate cancer progression and metastasis.
    Ricke WA; Ishii K; Ricke EA; Simko J; Wang Y; Hayward SW; Cunha GR
    Int J Cancer; 2006 May; 118(9):2123-31. PubMed ID: 16331600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of mesenchyme of the embryonic urogenital sinus and neonatal seminal vesicle on the cytodifferentiation of the Dunning tumor: ultrastructural study.
    Wong YC; Cunha GR; Hayashi N
    Acta Anat (Basel); 1992; 143(2):139-50. PubMed ID: 1598820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hedgehog signaling inhibition by the small molecule smoothened inhibitor GDC-0449 in the bone forming prostate cancer xenograft MDA PCa 118b.
    Karlou M; Lu JF; Wu G; Maity S; Tzelepi V; Navone NM; Hoang A; Logothetis CJ; Efstathiou E
    Prostate; 2012 Nov; 72(15):1638-47. PubMed ID: 22457212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchyme-induced changes in the neoplastic characteristics of the Dunning prostatic adenocarcinoma.
    Hayashi N; Cunha GR
    Cancer Res; 1991 Sep; 51(18):4924-30. PubMed ID: 1893381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.